ACRS Aclaris Therapeutics, Inc. - Common Stock
$6,09
Cena · Sie 18, 2026
Dane fundamentalne na dzień Sie 6, 2026
Zakres 52 tyg.
$2–$7
91% of range
Ocena Analityków
STRONG BUY
18 analysts
Cena Docelowa
$10
+68% upside
P/E (TTM)
-11.5
ROE
-55.3%
Marża Zysku Netto
-829.6%
ACRS Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$6.09
Kapitalizacja Rynkowa
$733M
P/E (TTM)
-11.5
EPS (TTM)
$-0.53
Przychody (TTM)
$8M
Stopa dywidendy
—
ROE
-55.3%
D/E Dług/Kapitał
—
Zakres 52 tyg.
$2 – $7
ACRS Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Configure
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody i Zysk Netto
$8M
2017-12-31
→
2025-12-31
EPS
$-0.53
2019-12-31
→
2025-12-31
Wolny przepływ pieniężny
$-47M
2016-12-31
→
2025-12-31
Marże
-829.6%
2017-12-31
→
2018-12-31
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
Wskaźnik
Trend 5-letni
ACRS
Mediana porównawcza
P/E (TTM)
-11.5
11.7
P/S (TTM)
93.7
5.4
P/B
7.1
3.2
Price / FCF (Cena / FCF)
-15.5
—
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
Wskaźnik
Trend 5-letni
ACRS
Mediana porównawcza
Operating Margin (Marża Operacyjna)
-975.9%
—
Net Profit Margin (Marża Zysku Netto)
-829.6%
-33.0%
ROA
-34.1%
-25.6%
ROE
-55.3%
-21.8%
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
Wskaźnik
Trend 5-letni
ACRS
Mediana porównawcza
Current Ratio (Wskaźnik bieżący)
3.4
4.1
Quick Ratio (Wskaźnik Szybkości)
0.7
—
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
Wskaźnik
Trend 5-letni
ACRS
Mediana porównawcza
Revenue YoY (Przychody R/R)
-58.2%
—
Revenue CAGR 3Y (Przychody CAGR 3L)
-35.9%
—
Revenue CAGR 5Y (Przychody CAGR 5L)
3.8%
—
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
Wskaźnik
Trend 5-letni
ACRS
Mediana porównawcza
ACRS Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
KUP
18 analityków
- Mocne kupno 8 44,4%
- Kup 8 44,4%
- Trzymaj 2 11,1%
- Sprzedaj 0 0,0%
- Mocna sprzedaż 0 0,0%
12-miesięczny cel cenowy
10 analityków · 2026-08-16
Mediana
$10.00
Teraz
$6.09
Niski
$4.00
Wysoki
$16.00
Średni cel
$10.00
+64,3%
Średnia cel
$10.20
+67,6%
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
0.01%
| Okres | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|
| 30 czerwca 2026 | $-0.15 | $-0.16 | 0.01% |
| 31 marca 2026 | $-0.15 | $-0.16 | 0.01% |
| 31 grudnia 2025 | $-0.16 | $-0.15 | -0.01% |
| 30 września 2025 | $-0.12 | $-0.14 | 0.02% |
| 30 czerwca 2025 | $-0.13 | $-0.14 | 0.01% |
| 31 marca 2025 | $-0.12 | $-0.12 | -0.00% |
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| ACRS | $363M | -5.7 | -58.2% | -829.6% | -55.3% | — |
| LXRX | $421M | -8.2 | 60.2% | -101.1% | -39.7% | — |
| PCRX | $1.06B | 161.8 | 3.6% | 0.97% | 0.97% | — |
| COLL | $1.47B | 26.8 | 23.6% | 8.1% | 23.5% | 59.4% |
| AMPH | $1.22B | 13.2 | -1.7% | 13.6% | 12.7% | 49.5% |
| SGP | — | — | — | — | 50.0% | — |
| PHAT | $1.18B | -5.5 | 216.9% | -126.4% | 52.4% | 87.1% |
| CRMD | $922M | 5.7 | 617.0% | 52.3% | 52.1% | 88.5% |
| ARVN | $753M | -10.4 | -0.30% | -30.8% | -15.5% | — |
| LLY | — | 46.8 | 44.7% | 31.7% | 101.2% | — |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat 17
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $8M | $19M | $31M | $30M | $7M | $6M | $4M | $6M | $2M | |
| Cost of Revenue | $2M | $3M | $3M | $4M | $5M | $5M | $4M | $4M | $1M | |
| Gross Profit | · | · | · | · | · | · | · | $3M | $476.0K | |
| R&D Expense | $53M | $34M | $98M | $78M | $44M | $29M | $64M | $61M | $36M | |
| SG&A Expense | $22M | $22M | $32M | $25M | $24M | $21M | $28M | $26M | $19M | |
| Operating Expenses | $84M | $161M | $129M | $120M | $96M | $57M | $115M | $91M | $56M | |
| Operating Income | $-76M | $-142M | $-97M | $-90M | $-90M | $-51M | $-111M | $-85M | $-54M | |
| Interest Income | $8M | $8M | $9M | · | · | · | · | · | · | |
| Other Non-op | $11M | $10M | $9M | $3M | $-1M | $-424.0K | $-2M | $3M | $2M | |
| Pretax Income | $-65M | $-132M | $-89M | $-87M | $-91M | $-51M | $-114M | $-82M | $-70M | |
| Income Tax | · | · | $-367.0K | · | · | $-182.0K | · | · | $-2M | |
| Net Income | $-65M | $-132M | $-88M | $-87M | $-91M | $-51M | $-161M | $-133M | $-69M | |
| EPS (Basic) | $-0.53 | $-1.71 | $-1.27 | $-1.33 | $-1.60 | $-1.20 | $-3.90 | · | · | |
| EPS (Diluted) | $-0.53 | $-1.71 | $-1.27 | $-1.33 | $-1.60 | $-1.20 | $-3.90 | · | · | |
| Shares (Basic) | 122,564,741 | 77,296,665 | 69,808,855 | 65,213,944 | 56,730,583 | 42,539,293 | 41,323,921 | · | · | |
| Shares (Diluted) | 122,564,741 | 77,296,665 | 69,808,855 | 65,213,944 | 56,730,583 | 42,539,293 | 41,323,921 | · | · | |
| EBITDA | $-76M | $-141M | $-96M | $-89M | $-89M | $-50M | $-105M | $-134M | $-72M |
Bilans 27
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $20M | $25M | $40M | $45M | $27M | $22M | $34M | $168M | $20M | |
| Receivables | · | $318.0K | $298.0K | $484.0K | $623.0K | $772.0K | $704.0K | $563.0K | $481.0K | |
| Inventory | · | · | · | · | · | · | $0 | $791.0K | · | |
| Prepaid Expense | · | $12M | $9M | $13M | $13M | $3M | $3M | $5M | $6M | |
| Current Assets | $96M | $126M | $129M | $232M | $205M | $57M | $84M | $179M | $200M | |
| PP&E (Net) | $761.0K | $1M | $2M | $1M | $1M | $2M | $2M | $2M | $2M | |
| PP&E (Gross) | · | $6M | $6M | $5M | $5M | $4M | $5M | $4M | $3M | |
| Accum. Depreciation | · | $5M | $4M | $4M | $3M | $3M | $2M | $1M | $480.0K | |
| Goodwill | · | · | · | · | · | · | · | $19M | $19M | |
| Intangibles | · | · | $269.0K | $7M | $7M | $7M | $7M | $7M | $7M | |
| Other Non-current Assets | $3M | $3M | $4M | $3M | $4M | $5M | $5M | $332.0K | $279.0K | |
| Total Assets | $160M | $220M | $197M | $255M | $251M | $71M | $98M | $276M | $244M | |
| Accounts Payable | $13M | $5M | $9M | $10M | $10M | $5M | $10M | $12M | $8M | |
| Accrued Liabilities | $9M | $20M | $19M | $9M | $10M | $6M | $8M | $8M | $5M | |
| Current Liabilities | $29M | $32M | $31M | $22M | $23M | $15M | $22M | $27M | $13M | |
| Capital Leases | $2M | $2M | $3M | $2M | $2M | $3M | $4M | · | · | |
| Deferred Tax | · | · | · | $367.0K | $367.0K | $367.0K | $549.0K | $549.0K | $549.0K | |
| Other Non-current Liabilities | $2M | $4M | $3M | $2M | $2M | $3M | $4M | $476.0K | $558.0K | |
| Total Liabilities | $57M | $65M | $40M | $57M | $54M | $33M | $28M | $60M | $18M | |
| Long-term Debt | · | · | · | · | · | $11M | · | $30M | · | |
| Common Stock | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | · | · | · | · | |
| Paid-in Capital | $1.07B | $1.06B | $928M | $881M | $793M | $542M | $524M | $507M | $385M | |
| Retained Earnings | $-968M | $-903M | $-771M | $-682M | $-595M | $-505M | $-454M | $-292M | $-159M | |
| AOCI | $610.0K | $97.0K | $-106.0K | $-897.0K | $-224.0K | $-94.0K | $-66.0K | $-69.0K | $-246.0K | |
| Stockholders' Equity | $103M | $156M | $157M | $198M | $197M | $38M | $70M | $215M | $225M | |
| Liabilities + Equity | $160M | $220M | $197M | $255M | $251M | $71M | $98M | $276M | $244M | |
| Shares Outstanding | 120,499,433 | 107,850,124 | 70,894,889 | 66,688,647 | 61,228,446 | 45,109,314 | 41,485,638 | 41,210,725 | 30,856,505 |
Przepływy pieniężne 11
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $454.0K | $807.0K | $863.0K | $797.0K | $923.0K | $1M | $6M | $2M | $402.0K | |
| Stock-based Comp | $12M | $11M | $21M | $15M | $14M | $11M | $16M | $20M | $14M | |
| Amort. of Intangibles | · | · | $75.0K | $75.0K | $75.0K | $75.0K | $75.0K | $75.0K | $31.0K | |
| Restructuring | · | · | $3M | · | · | · | · | · | · | |
| Other Non-cash | $5M | $100M | $-11M | $4M | $24M | $-149.0K | $42M | $10M | $-972.0K | |
| Operating Cash Flow | $-47M | $-20M | $-78M | $-68M | $-52M | $-39M | $-96M | $-101M | $-55M | |
| CapEx | $111.0K | $121.0K | $1M | $605.0K | $308.0K | $453.0K | $2M | $1M | $1M | |
| Investing Cash Flow | $48M | $-70M | $46M | $13M | $-168M | $6M | $106M | $9M | $-56M | |
| Financing Cash Flow | $-6M | $75M | $27M | $73M | $225M | $18M | $-30M | $128M | $100M | |
| Net Change in Cash | $-5M | $-15M | $-5M | $18M | $5M | $-14M | $-21M | $37M | $-10M | |
| Free Cash Flow | $-47M | $-20M | $-80M | $-68M | $-52M | $-39M | $-98M | $-102M | $-56M |
Rentowność 8
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | · | 32.1% | 28.3% | |
| Operating Margin | -975.9% | -758.2% | -311.6% | -302.0% | -1327.1% | -785.4% | -2627.3% | -1341.9% | -4303.2% | |
| Net Margin | -829.6% | -705.5% | -283.2% | -292.1% | -1344.0% | -787.0% | -3817.2% | -1315.4% | -4071.5% | |
| Pretax Margin | -829.6% | -705.5% | -284.3% | -292.1% | -1344.0% | -792.0% | -3817.2% | -1315.4% | -4180.2% | |
| EBITDA Margin | -970.1% | -753.9% | -308.8% | -299.3% | -1313.4% | -765.0% | -2475.7% | -1323.3% | -4279.3% | |
| ROA | -34.1% | -63.2% | -39.1% | -34.4% | -56.4% | -60.3% | -86.3% | -51.1% | -32.7% | |
| ROE | -55.3% | -92.5% | -56.5% | -41.6% | -43.9% | -130.1% | -207.9% | -73.5% | -34.7% | |
| ROIC | · | · | -61.7% | · | · | -134.8% | · | · | -31.3% |
Płynność i wypłacalność 2
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.4 | 4.0 | 4.2 | 10.6 | 8.9 | 3.9 | 3.7 | 6.6 | 15.7 | |
| Quick Ratio | 0.7 | 0.8 | 1.3 | 2.1 | 1.2 | 1.5 | 3.4 | 6.3 | 1.6 |
Efektywność 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.1 | 0.1 | 0.1 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | |
| Inventory Turnover | · | · | · | · | · | · | 10.3 | 17.3 | · | |
| Receivables Turnover | · | 60.8 | 79.9 | 53.8 | 9.7 | 8.8 | 6.7 | 3.8 | 7.0 |
Stopy Wzrostu 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -58.2% | -40.1% | 5.0% | 340.1% | 4.3% | · | · | · | · | |
| Revenue CAGR 3Y | -35.9% | 40.4% | 68.9% | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 3.8% | · | · | · | · | · | · | · | · |
Wycena (TTM) 10
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $8M | $19M | $31M | $30M | $7M | $6M | $4M | $6M | $2M | |
| Net Income TTM | $-65M | $-132M | $-88M | $-87M | $-91M | $-51M | $-161M | $-133M | $-69M | |
| Market Cap | $363M | $267M | $74M | $1.05B | $890M | $292M | $78M | $305M | $760M | |
| P/E | -5.7 | -1.5 | -0.8 | -11.8 | -9.1 | -5.4 | -0.5 | · | · | |
| P/S | 46.3 | 14.3 | 2.4 | 35.3 | 131.7 | 45.0 | 18.5 | 49.5 | 451.8 | |
| P/B | 3.5 | 1.7 | 0.5 | 5.3 | 4.5 | 7.8 | 1.1 | 1.4 | 3.4 | |
| P / Tangible Book | 3.5 | 1.7 | 0.5 | 5.5 | 4.7 | 9.6 | · | · | · | |
| P / Cash Flow | -7.7 | -13.3 | -1.0 | -15.5 | -17.1 | -7.6 | -0.8 | -3.0 | -13.9 | |
| P / FCF | -7.7 | -13.2 | -0.9 | -15.4 | -17.0 | -7.5 | -0.8 | -3.0 | -13.6 | |
| Earnings Yield | -17.6% | -69.0% | -121.0% | -8.4% | -11.0% | -18.6% | -206.3% | · | · |
Rachunek zysków i strat 15
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2M | $2M | $1M | $3M | $2M | $1M | $9M | $4M | $3M | $2M | $18M | $9M | $2M | $3M | $8M | $19M | |
| Cost of Revenue | $218.0K | $395.0K | $532.0K | $538.0K | $515.0K | $506.0K | $705.0K | $654.0K | $624.0K | $809.0K | $725.0K | $848.0K | $1M | $808.0K | $877.0K | $923.0K | |
| R&D Expense | $18M | $16M | $17M | $13M | $11M | $12M | $9M | $6M | $9M | $10M | $27M | $24M | $25M | $23M | $21M | $24M | |
| SG&A Expense | $6M | $7M | $6M | $5M | $5M | $6M | $5M | $6M | $5M | $7M | $8M | $7M | $8M | $9M | $7M | $6M | |
| Operating Expenses | $26M | $24M | $24M | $20M | $20M | $20M | $109M | $15M | $16M | $21M | $22M | $41M | $34M | $32M | $37M | $40M | |
| Operating Income | $-24M | $-22M | $-23M | $-17M | $-18M | $-18M | $-100M | $-10M | $-13M | $-19M | $-4M | $-32M | $-32M | $-30M | $-29M | $-21M | |
| Interest Income | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | · | · | · | |
| Other Non-op | $3M | $2M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $922.0K | |
| Pretax Income | · | · | $-20M | $-15M | $-15M | $-15M | $-97M | $-8M | $-11M | $-17M | · | · | · | · | · | · | |
| Net Income | $-22M | $-20M | $-20M | $-15M | $-15M | $-15M | $-97M | $-8M | $-11M | $-17M | $-1M | $-29M | $-30M | $-28M | $-28M | $-20M | |
| EPS (Basic) | $-0.15 | $-0.15 | $-0.16 | $-0.12 | $-0.13 | $-0.12 | $-1.21 | $-0.11 | $-0.15 | $-0.24 | $-0.02 | $-0.41 | $-0.42 | $-0.42 | $-0.41 | $-0.30 | |
| EPS (Diluted) | $-0.15 | $-0.15 | $-0.16 | $-0.12 | $-0.13 | $-0.12 | $-1.21 | $-0.11 | $-0.15 | $-0.24 | $-0.02 | $-0.41 | $-0.42 | $-0.42 | $-0.41 | $-0.30 | |
| Shares (Basic) | 142,736,848 | 128,810,050 | -245,025,840 | 122,619,311 | 122,580,967 | 122,390,303 | -136,451,324 | 71,381,731 | 71,291,400 | 71,074,858 | -138,505,385 | 70,807,934 | 70,633,528 | 66,872,778 | -128,882,450 | 66,675,337 | |
| Shares (Diluted) | 142,736,848 | 128,810,050 | -245,025,840 | 122,619,311 | 122,580,967 | 122,390,303 | -136,451,324 | 71,381,731 | 71,291,400 | 71,074,858 | -138,505,385 | 70,807,934 | 70,633,528 | 66,872,778 | -128,882,450 | 66,675,337 | |
| EBITDA | $-24M | $-22M | · | $-17M | $-18M | $-18M | · | $-10M | $-13M | $-19M | · | $-32M | $-32M | $-30M | · | $-21M |
Bilans 24
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $19M | $29M | $20M | $25M | $25M | $30M | $25M | $48M | $23M | $36M | $40M | $39M | $31M | $45M | $45M | $62M | |
| Receivables | · | · | · | · | $194.0K | $250.0K | · | $343.0K | $325.0K | $373.0K | $298.0K | $346.0K | $431.0K | $686.0K | $484.0K | $597.0K | |
| Prepaid Expense | · | · | · | · | $4M | $3M | · | $4M | $6M | $7M | $9M | $20M | $13M | $13M | $13M | $8M | |
| Current Assets | $98M | $110M | $96M | $101M | $104M | $109M | $126M | $132M | $118M | $135M | $129M | $123M | $133M | $184M | $232M | $257M | |
| PP&E (Net) | $664.0K | $750.0K | $761.0K | $811.0K | $868.0K | $942.0K | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | |
| PP&E (Gross) | · | · | · | $6M | $6M | $6M | · | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $5M | $5M | |
| Accum. Depreciation | · | · | · | $5M | $5M | $5M | · | $5M | $5M | $4M | $4M | $5M | $4M | $4M | $4M | $4M | |
| Intangibles | · | · | · | · | · | · | · | · | · | · | · | $7M | $7M | $7M | $7M | $7M | |
| Other Non-current Assets | $2M | $2M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $4M | $4M | $3M | $3M | $3M | $3M | $3M | |
| Total Assets | $180M | $199M | $160M | $176M | $189M | $198M | $220M | $182M | $161M | $174M | $197M | $218M | $236M | $230M | $255M | $268M | |
| Accounts Payable | $16M | $15M | $13M | $9M | $9M | $6M | $5M | $8M | $7M | $11M | $9M | $10M | $11M | $8M | $10M | $8M | |
| Accrued Liabilities | $6M | $6M | $9M | $10M | $11M | $9M | $20M | $5M | $6M | $7M | $19M | $15M | $9M | $7M | $9M | $9M | |
| Current Liabilities | $28M | $27M | $29M | $26M | $27M | $22M | $32M | $19M | $16M | $20M | $31M | $27M | $23M | $18M | $22M | $20M | |
| Capital Leases | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | · | $367.0K | $367.0K | $367.0K | $367.0K | $367.0K | |
| Other Non-current Liabilities | $1M | $1M | $2M | $2M | $2M | $4M | $4M | $2M | $2M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | |
| Total Liabilities | $55M | $55M | $57M | $55M | $57M | $54M | $65M | $52M | $27M | $32M | $40M | $62M | $56M | $53M | $57M | $48M | |
| Common Stock | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | |
| Paid-in Capital | $1.13B | $1.13B | $1.07B | $1.07B | $1.06B | $1.06B | $1.06B | $936M | $933M | $930M | $928M | $927M | $921M | $888M | $881M | $876M | |
| Retained Earnings | $-1.01B | $-988M | $-968M | $-948M | $-933M | $-918M | $-903M | $-806M | $-799M | $-788M | $-771M | $-769M | $-740M | $-710M | $-682M | $-655M | |
| AOCI | $-304.0K | $22.0K | $610.0K | $597.0K | $482.0K | $434.0K | $97.0K | $427.0K | $-463.0K | $-364.0K | $-106.0K | $-1M | $-1M | $-354.0K | $-897.0K | $-1M | |
| Stockholders' Equity | $125M | $144M | $103M | $120M | $132M | $144M | $156M | $130M | $134M | $142M | $157M | $156M | $180M | $177M | $198M | $220M | |
| Liabilities + Equity | $180M | $199M | $160M | $176M | $189M | $198M | $220M | $182M | $161M | $174M | $197M | $218M | $236M | $230M | $255M | $268M | |
| Shares Outstanding | 139,824,273 | 139,652,849 | 120,499,433 | 108,342,592 | 108,328,794 | 108,265,529 | 107,850,124 | 71,417,513 | 71,332,825 | 71,248,017 | 70,894,889 | 70,818,954 | 70,769,702 | 67,206,025 | 66,688,647 | 66,679,641 |
Przepływy pieniężne 11
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $107.0K | $102.0K | $102.0K | $110.0K | $114.0K | $128.0K | $143.0K | $179.0K | $242.0K | $243.0K | $228.0K | $219.0K | $218.0K | $198.0K | $190.0K | $193.0K | |
| Stock-based Comp | $3M | $3M | $3M | $3M | $3M | $4M | $3M | $3M | $3M | $2M | $1M | $6M | $7M | $7M | $5M | $4M | |
| Amort. of Intangibles | · | · | · | · | · | · | · | · | · | · | · | $19.0K | $19.0K | $19.0K | $18.0K | $19.0K | |
| Restructuring | · | · | · | · | · | · | · | $32.0K | $98.0K | $3M | · | · | · | · | · | · | |
| Other Non-cash | · | $-2M | · | · | · | $-2M | · | · | · | $-6M | · | · | · | $-5M | · | · | |
| Operating Cash Flow | $-20M | $-18M | $-13M | $-11M | $-10M | $-13M | $-9M | $22M | $-12M | $-21M | $-7M | $-25M | $-21M | $-26M | $-19M | $-8M | |
| CapEx | $58.0K | $13.0K | $24.0K | $23.0K | $21.0K | $43.0K | $0 | $0 | $-14.0K | $135.0K | $441.0K | $84.0K | $231.0K | $553.0K | $105.0K | $150.0K | |
| Investing Cash Flow | $10M | $-31M | $10M | $14M | $5M | $19M | $-89M | $3M | $-674.0K | $17M | $8M | $33M | $-20M | $26M | $3M | $1M | |
| Financing Cash Flow | $91.0K | $58M | $-3M | $-3M | $-9.0K | $-275.0K | $75M | $22.0K | $-11.0K | $-55.0K | $49.0K | $-87.0K | · | · | $37.0K | $-11.0K | |
| Net Change in Cash | $-9M | $9M | $-5M | $-146.0K | $-5M | $6M | $-23M | $25M | $-13M | $-4M | $838.0K | $8M | $-14M | $-555.0K | $-16M | $-7M | |
| Free Cash Flow | · | $-18M | · | · | · | $-13M | · | · | · | $-21M | · | · | · | $-27M | · | · |
Rentowność 6
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1487.9% | -1111.8% | · | -519.8% | -1035.9% | -1242.9% | · | -240.9% | -464.7% | -789.4% | · | -340.2% | -1702.2% | -1183.5% | · | -109.8% | |
| Net Margin | -1320.1% | -993.2% | · | -443.0% | -868.3% | -1036.8% | · | -174.6% | -397.2% | -706.5% | · | -315.2% | -1582.1% | -1113.9% | · | -104.9% | |
| Pretax Margin | · | · | · | -443.0% | -868.3% | -1036.8% | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -1487.9% | -1106.7% | · | -519.8% | -1035.9% | -1234.1% | · | -240.9% | -464.7% | -779.3% | · | -340.2% | -1702.2% | -1175.6% | · | -109.8% | |
| ROA | -11.7% | -10.0% | · | -8.2% | -8.8% | -8.1% | · | -3.8% | -5.5% | -8.4% | · | -12.0% | -11.5% | -12.3% | · | -7.5% | |
| ROE | -16.8% | -13.8% | · | -11.7% | -11.6% | -10.5% | · | -5.3% | -7.0% | -10.6% | · | -15.6% | -14.2% | -15.8% | · | -9.1% |
Płynność i wypłacalność 2
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.5 | 4.0 | · | 3.9 | 3.9 | 5.1 | · | 7.0 | 7.5 | 6.7 | · | 4.5 | 5.8 | 10.1 | · | 13.0 | |
| Quick Ratio | 0.7 | 1.0 | · | 1.0 | 1.0 | 1.4 | · | 2.6 | 1.5 | 1.8 | · | 1.4 | 1.4 | 2.5 | · | 3.1 |
Efektywność 2
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.1 | |
| Receivables Turnover | · | · | · | · | 6.8 | 4.7 | · | 12.6 | 7.3 | 4.5 | · | 19.7 | 3.5 | 3.8 | · | 27.0 |
Wycena (TTM) 10
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $9M | $9M | · | $11M | $10M | $11M | · | $19M | $16M | $16M | · | $33M | $25M | $25M | · | $24M | |
| Net Income TTM | $-71M | $-65M | · | $-53M | $-49M | $-51M | · | $-65M | $-87M | $-104M | · | $-107M | $-98M | $-87M | · | $-80M | |
| Market Cap | $740M | $524M | · | $206M | $154M | $166M | · | $82M | $78M | $88M | · | $485M | $734M | $544M | · | $1.05B | |
| P/E | -9.6 | -7.2 | · | -4.0 | -2.8 | -2.5 | · | -1.3 | -0.9 | -0.8 | · | -4.4 | -7.2 | -6.0 | · | -12.4 | |
| P/S | 85.0 | 61.4 | · | 18.9 | 14.9 | 15.1 | · | 4.4 | 4.8 | 5.5 | · | 14.8 | 29.4 | 22.2 | · | 44.4 | |
| P/B | 5.9 | 3.6 | · | 1.7 | 1.2 | 1.1 | · | 0.6 | 0.6 | 0.6 | · | 3.1 | 4.1 | 3.1 | · | 4.8 | |
| P / Tangible Book | 5.9 | 3.6 | · | 1.7 | 1.2 | 1.1 | · | 0.6 | 0.6 | 0.6 | · | 3.2 | 4.2 | 3.2 | · | 4.9 | |
| P / Cash Flow | · | -28.9 | · | · | · | -12.7 | · | · | · | -4.2 | · | · | · | -20.6 | · | · | |
| P / FCF | · | -28.8 | · | · | · | -12.6 | · | · | · | -4.2 | · | · | · | -20.2 | · | · | |
| Earnings Yield | -10.4% | -13.9% | · | -25.3% | -35.9% | -40.5% | · | -79.1% | -110.9% | -120.2% | · | -22.6% | -14.0% | -16.6% | · | -8.1% |
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
Rachunek zysków i strat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Przychody | $8M | $19M | $31M | $30M | $7M |
| Marża Operacyjna % | -975.9% | -758.2% | -311.6% | -302.0% | -1327.1% |
| Zysk netto | $-65M | $-132M | $-88M | $-87M | $-91M |
| Rozwodniony EPS | $-0.53 | $-1.71 | $-1.27 | $-1.33 | $-1.60 |
Bilans
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wskaźnik bieżący | 3.4 | 4.0 | 4.2 | 10.6 | 8.9 |
| Wskaźnik Szybkości | 0.7 | 0.8 | 1.3 | 2.1 | 1.2 |
Przepływy pieniężne
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $-47M | $-20M | $-80M | $-68M | $-52M |
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
📊
Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Właściciele instytucjonalni (13F) 160 emitentów · $533.8M łącznie · Na dzień 30 czerwca 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 34 (+3 vs poprzedni kw.) | 13 (-1 vs poprzedni kw.) | 61 (+22 vs poprzedni kw.) | 35 (-4 vs poprzedni kw.) | +16.3M |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | $67 304 808 | 12 723 026 | 12,61% | Akcje |
| BML Capital Management, LLC | $63 347 750 | 11 975 000 | 11,87% | Akcje |
| Deep Track Capital, LP | $49 435 050 | 9 345 000 | 9,26% | Akcje |
| Vivo Capital, LLC | $35 414 630 | 6 694 637 | 6,63% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $30 776 511 | 5 817 866 | 5,77% | Akcje |
| Frazier Life Sciences Management, L.P. | $26 055 228 | 4 925 374 | 4,88% | Akcje |
| Rock Springs Capital Management LP | $22 908 514 | 4 330 532 | 4,29% | Akcje |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $21 535 590 | 4 071 000 | 4,03% | Akcje |
| Decheng Capital LLC | $21 380 783 | 4 041 736 | 4,01% | Akcje |
| STATE STREET CORP | $17 220 749 | 3 255 340 | 3,23% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $14 410 007 | 2 723 241 | 2,70% | Akcje |
| BRAIDWELL LP | $11 333 021 | 2 142 348 | 2,12% | Akcje |
| Balyasny Asset Management L.P. | $10 704 156 | 2 023 470 | 2,01% | Akcje |
| SILVERARC CAPITAL MANAGEMENT, LLC | $10 296 890 | 1 946 482 | 1,93% | Akcje |
| Kalehua Capital Management LLC | $9 693 211 | 1 832 365 | 1,82% | Akcje |
| Jones Hill Capital LP | $9 307 713 | 1 759 492 | 1,74% | Akcje |
| Palo Alto Investors LP | $8 535 045 | 1 613 430 | 1,60% | Akcje |
| Woodline Partners LP | $8 522 476 | 1 611 054 | 1,60% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $7 753 738 | 1 465 735 | 1,45% | Akcje |
| PANAGORA ASSET MANAGEMENT INC | $7 174 044 | 1 356 152 | 1,34% | Akcje |
| Connor, Clark & Lunn Investment Management Ltd. | $6 400 297 | 1 209 886 | 1,20% | Akcje |
| MPM BIOIMPACT LLC | $5 514 650 | 1 042 467 | 1,03% | Akcje |
| Aldebaran Capital, LLC | $4 955 307 | 936 731 | 0,93% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $4 798 945 | 907 173 | 0,90% | Akcje |
| RENAISSANCE TECHNOLOGIES LLC | $4 324 739 | 817 531 | 0,81% | Akcje |
| Three Bridge Wealth Advisors, LLC | $3 781 414 | 714 823 | 0,71% | Akcje |
| MILLENNIUM MANAGEMENT LLC | $2 771 405 | 523 895 | 0,52% | Akcje |
| CITADEL ADVISORS LLC | $2 756 090 | 521 000 | 0,52% | Opcja kupna |
| Aisling Capital Management LP | $2 298 267 | 434 455 | 0,43% | Akcje |
| DIMENSIONAL FUND ADVISORS LP | $2 263 078 | 427 803 | 0,42% | Akcje |
| ORBIMED ADVISORS LLC | $2 229 735 | 421 500 | 0,42% | Akcje |
| D. E. Shaw & Co., Inc. | $2 192 700 | 414 499 | 0,41% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2 182 384 | 412 549 | 0,41% | Akcje |
| Tetragon Partners GP Ltd | $2 116 000 | 400 000 | 0,40% | Akcje |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1 830 647 | 346 058 | 0,34% | Akcje |
| GOLDMAN SACHS GROUP INC | $1 546 352 | 292 316 | 0,29% | Akcje |
| FMR LLC | $1 534 645 | 290 103 | 0,29% | Akcje |
| SUPERSTRING CAPITAL MANAGEMENT LP | $1 363 101 | 257 675 | 0,26% | Akcje |
| HighTower Advisors, LLC | $1 150 702 | 217 524 | 0,22% | Akcje |
| Logos Global Management LP | $1 058 000 | 200 000 | 0,20% | Akcje |
| CITADEL ADVISORS LLC | $997 075 | 188 483 | 0,19% | Akcje |
| Verdad Advisers, LP | $927 189 | 175 272 | 0,17% | Akcje |
| KOTLER KEVIN | $920 846 | 305 929 | 0,17% | Akcje |
| Informed Momentum Co LLC | $906 320 | 171 327 | 0,17% | Akcje |
| Assenagon Asset Management S.A. | $817 591 | 154 554 | 0,15% | Akcje |
| Atom Investors LP | $787 443 | 148 855 | 0,15% | Akcje |
| TWO SIGMA ADVISERS, LP | $768 754 | 255 400 | 0,14% | Akcje |
| RHUMBLINE ADVISERS | $757 603 | 143 216 | 0,14% | Akcje |
| ALPS ADVISORS INC | $749 852 | 141 749 | 0,14% | Akcje |
| SEI INVESTMENTS CO | $734 136 | 138 778 | 0,14% | Akcje |
| TWO SIGMA INVESTMENTS, LP | $703 930 | 133 068 | 0,13% | Akcje |
| Vanguard Global Advisers, LLC | $682 706 | 129 056 | 0,13% | Akcje |
| Hudson Bay Capital Management LP | $634 800 | 120 000 | 0,12% | Akcje |
| CenterBook Partners LP | $625 426 | 118 228 | 0,12% | Akcje |
| CITIGROUP INC | $586 904 | 110 946 | 0,11% | Akcje |
| WELLS FARGO & COMPANY/MN | $558 857 | 105 644 | 0,10% | Akcje |
| CITADEL ADVISORS LLC | $550 160 | 104 000 | 0,10% | Opcja sprzedaży |
| Verition Fund Management LLC | $518 420 | 98 000 | 0,10% | Akcje |
| BlackRock, Inc. | $478 761 | 90 503 | 0,09% | Akcje |
| WELLINGTON MANAGEMENT GROUP LLP | $448 253 | 84 736 | 0,08% | Akcje |
| Bank of New York Mellon Corp | $430 839 | 81 444 | 0,08% | Akcje |
| STRS OHIO | $430 606 | 81 400 | 0,08% | Akcje |
| BANK OF AMERICA CORP /DE/ | $427 332 | 80 781 | 0,08% | Akcje |
| Voleon Capital Management LP | $408 219 | 77 168 | 0,08% | Akcje |
| Susquehanna Portfolio Strategies, LLC | $403 468 | 76 270 | 0,08% | Akcje |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $396 851 | 75 019 | 0,07% | Akcje |
| MetLife Investment Management, LLC | $368 708 | 69 699 | 0,07% | Akcje |
| BARCLAYS PLC | $349 151 | 66 002 | 0,07% | Akcje |
| JPMORGAN CHASE & CO | $341 772 | 68 082 | 0,06% | Akcje |
| AQR CAPITAL MANAGEMENT LLC | $313 332 | 59 231 | 0,06% | Akcje |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $288 718 | 54 578 | 0,05% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $280 899 | 53 100 | 0,05% | Opcja sprzedaży |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $271 906 | 51 400 | 0,05% | Opcja kupna |
| MANGROVE PARTNERS IM, LLC | $266 039 | 50 291 | 0,05% | Akcje |
| Invesco Ltd. | $246 905 | 46 674 | 0,05% | Akcje |
| DIVERSIFIED TRUST CO | $240 816 | 45 523 | 0,05% | Akcje |
| ALLIANCEBERNSTEIN L.P. | $213 750 | 57 000 | 0,04% | Akcje |
| Police & Firemen's Retirement System of New Jersey | $205 390 | 38 826 | 0,04% | Akcje |
| BNP PARIBAS FINANCIAL MARKETS | $187 922 | 35 524 | 0,04% | Akcje |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $171 428 | 32 406 | 0,03% | Akcje |
| PROFUND ADVISORS LLC | $161 271 | 30 486 | 0,03% | Akcje |
| State of Wyoming | $145 152 | 27 439 | 0,03% | Akcje |
| NEW YORK STATE COMMON RETIREMENT FUND | $144 417 | 27 300 | 0,03% | Akcje |
| Nuveen, LLC | $139 503 | 26 371 | 0,03% | Akcje |
| INTECH INVESTMENT MANAGEMENT LLC | $130 494 | 24 668 | 0,02% | Akcje |
| VOYA INVESTMENT MANAGEMENT LLC | $122 220 | 23 104 | 0,02% | Akcje |
| China Universal Asset Management Co., Ltd. | $117 586 | 22 228 | 0,02% | Akcje |
| Rafferty Asset Management, LLC | $116 364 | 21 997 | 0,02% | Akcje |
| PRUDENTIAL FINANCIAL INC | $107 228 | 20 270 | 0,02% | Akcje |
| ProShare Advisors LLC | $106 302 | 20 095 | 0,02% | Akcje |
| Verition Fund Management LLC | $105 800 | 20 000 | 0,02% | Opcja kupna |
| VANGUARD GROUP INC | $103 661 | 34 439 | 0,02% | Akcje |
| Walleye Capital LLC | $103 557 | 19 576 | 0,02% | Akcje |
| NEUBERGER BERMAN GROUP LLC | $101 991 | 19 280 | 0,02% | Akcje |
| NORTHERN TRUST CORP | $98 463 | 18 613 | 0,02% | Akcje |
| Vontobel Holding Ltd. | $95 220 | 18 000 | 0,02% | Akcje |
| CRA Financial Services, LLC | $94 067 | 17 782 | 0,02% | Akcje |
| Empirical Financial Services, LLC d.b.a. Empirical Wealth Management | $85 021 | 16 072 | 0,02% | Akcje |
| Vanguard Personalized Indexing Management, LLC | $83 005 | 15 691 | 0,02% | Akcje |
| Dynamic Technology Lab Private Ltd | $72 000 | 13 521 | 0,01% | Akcje |
Insiderzy spółki 26 insiderów · 13 dyrektorzy generalni · 13 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Neal Walker | Interim President and CEO | 1 marca 2024 M | 1 279 445 | 0 | 0 | $0 |
| Douglas J. Manion | Pres and CEO | 1 stycznia 2024 M | 41 813 | 0 | 0 | $0 |
| Kevin Balthaser | Chief Financial Officer | 2 marca 2024 M | 23 983 | 0 | 0 | $0 |
| Frank Ruffo | Chief Financial Officer | 10 marca 2022 S | 201 883 | 0 | 0 | $0 |
| Roland Wilhelm Kolbeck | Chief Scientific Officer | 1 sierpnia 2026 M | 23 990 | 0 | 0 | $0 |
| Joseph Monahan | Chief Scientific Officer | 2 marca 2024 M | 186 783 | 0 | 0 | $0 |
| James Loerop | Chief Business Officer | 1 lutego 2024 A | 34 017 | 0 | 0 | $0 |
| Gail Cawkwell | Chief Medical Officer | 1 lipca 2023 M | 9 593 | 0 | 0 | $0 |
| Kamil Ali-Jackson | Chief Legal Officer | 3 stycznia 2022 M | 160 214 | 0 | 0 | $0 |
| David N. Gordon | Chief Medical Officer | 13 lipca 2021 S | 147 447 | 0 | 0 | $0 |
| Stuart Shanler | Chief Scientific Officer | 1 marca 2019 A | 272 047 | 0 | 0 | $0 |
| Brett Fair | Chief Commercial Officer | 1 lutego 2019 M | 10 582 | 0 | 0 | $0 |
| Christopher Powala | Chief Reg & Develop Officer | 1 lutego 2019 M | 141 729 | 0 | 0 | $0 |
| Maxine Gowen | Dyrektor | 5 czerwca 2026 M | 33 334 | 0 | 0 | $0 |
| Vincent Milano | Dyrektor | 5 czerwca 2026 M | 28 896 | 0 | 0 | $0 |
| Andrew N Schiff | Dyrektor | 5 czerwca 2026 M | 25 540 | 0 | 0 | $0 |
| William D. Humphries | Dyrektor | 4 czerwca 2026 A | 45 105 | 0 | 0 | $0 |
| Christopher P. Molineaux | Dyrektor | 4 czerwca 2026 A | 69 536 | 0 | 0 | $0 |
| Anand Mehra | Dyrektor | 4 czerwca 2026 A | 726 403 | 0 | 0 | $0 |
| Andrew Kenneth William Powell | Dyrektor | 4 marca 2024 P | 28 863 | 0 | 0 | $0 |
| Bryan M. Reasons | Dyrektor | 2 czerwca 2023 M | 24 072 | 0 | 0 | $0 |
| Stephen A. Tullman | Dyrektor | 4 października 2018 P | 177 457 | 0 | 0 | $0 |
| Rick Bierly | Dyrektor | 15 czerwca 2017 A | — | 0 | 0 | $0 |
| Albert Cha | Dyrektor | 29 czerwca 2016 A | 4 191 397 | 0 | 0 | $0 |
| Leonard Braden Michael | — | 23 kwietnia 2026 S | 13 950 000 | 0 | 1 | $-1 359 000 |
| FMR LLC | — | 21 sierpnia 2017 | — | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Aktywiści i właściciele 5%+ 4 akcje
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| M. Arkin (1999) Ltd., Moshe Arkin ×3 zgłoszenia | 19 grudnia 2019 | — | Pierwotne zgłoszenie | — | SEC |
| Vivo Ventures VII, LLC ×6 zgłoszenia | 14 lutego 2019 | — | Pierwotne zgłoszenie | — | SEC |
| Sofinnova Venture Partners VIII, L.P. (“SVP VIII”), Sofinnova Management VIII, L.L.C. (“SM VIII”), Dr. Michael F. Powell (“Powell”), Dr. James I. Healy (“Healy”), Dr. Anand Mehra (“Mehra”) ×3 zgłoszenia | 14 lutego 2018 | — | Pierwotne zgłoszenie | — | SEC |
| Vivo Ventures VII, LLC FEIN, Vivo Ventures Fund VII, L.P. FEIN, Vivo Ventures VII Affiliates Fund, L.P. FEIN | 20 października 2015 | — | Pierwotne zgłoszenie | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Posiadanie ETF-ów Posiadane przez 31 funduszy ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,64% | 24 606 SH | 8 sierpnia 2026 | Dziennie |
| SBIO · ALPS ETF Trust | 0,35% | 124 304 NS | 31 maja 2026 | N-PORT |
| IWC · iShares Trust | 0,16% | 403 020 SH | 8 sierpnia 2026 | Dziennie |
| VFMO · VANGUARD WELLINGTON FUND | 0,09% | 325 402 SH | 8 sierpnia 2026 | Dziennie |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,06% | 7 600 SH | 8 sierpnia 2026 | Dziennie |
| IBB · iShares Trust | 0,05% | 804 183 SH | 8 sierpnia 2026 | Dziennie |
| IWO · iShares Trust | 0,04% | 937 472 SH | 8 sierpnia 2026 | Dziennie |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,03% | 109 271 SH | 8 sierpnia 2026 | Dziennie |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,03% | 140 543 SH | 8 sierpnia 2026 | Dziennie |
| BIB · ProShares Trust | 0,03% | 4 459 NS | 31 maja 2026 | N-PORT |
| IWM · iShares Trust | 0,02% | 3 031 548 SH | 8 sierpnia 2026 | Dziennie |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,02% | 682 643 SH | 8 sierpnia 2026 | Dziennie |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,02% | 112 161 NS | 31 maja 2026 | N-PORT |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,02% | 8 224 SH | 8 sierpnia 2026 | Dziennie |
| RSSL · Global X Funds | 0,01% | 39 794 NS | 30 kwietnia 2026 | N-PORT |
| ITWO · ProShares Trust | 0,01% | 4 319 NS | 31 maja 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 1 449 139 SH | 8 sierpnia 2026 | Dziennie |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 14 250 SH | 8 sierpnia 2026 | Dziennie |
| VHT · VANGUARD WORLD FUND | 0,01% | 324 191 SH | 8 sierpnia 2026 | Dziennie |
| IWN · iShares Trust | 0,01% | 165 919 SH | 8 sierpnia 2026 | Dziennie |
| UWM · ProShares Trust | 0,01% | 3 377 NS | 31 maja 2026 | N-PORT |
| URTY · ProShares Trust | 0,00% | 3 414 NS | 31 maja 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,00% | 92 512 NS | 30 kwietnia 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 86 NS | 31 maja 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 275 717 SH | 8 sierpnia 2026 | Dziennie |
| IWV · iShares Trust | 0,00% | 39 408 SH | 8 sierpnia 2026 | Dziennie |
| DFAU · Dimensional ETF Trust | 0,00% | 26 214 NS | 30 kwietnia 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,00% | 404 NS | 30 kwietnia 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 21 533 NS | 30 kwietnia 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 4 243 349 SH | 8 sierpnia 2026 | Dziennie |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 9 978 SH | 8 sierpnia 2026 | Dziennie |